Reproductive Health Matters
Volume 16, Issue 32 , Pages 104-112 , November 2008

Making the case for cervical cancer prevention: what about equity?

  • Vivien D Tsu

      Affiliations

    • Associate Director for Reproductive Health, PATH, Seattle WA, USA
    • ,
  • Carol E Levin

      Affiliations

    • Senior Health Economist, PATH, Seattle WA, USA

References 

  1. Gonzalez Block MA, Sandiford P, Ruiz JA, et al. Beyond health gain: the range of health system benefits expressed by social groups in Mexico and Central America. Social Science and Medicine. 2001;52(10):1537–1550
  2. Gwatkin DR. Health inequalities and the health of the poor: what do we know? What can we do?. Bulletin of World Health Organization. 2000;78(1):3–18
  3. Kruk ME, Freedman LP. Assessing health system performance in developing countries: a review of the literature. Health Policy. 2008;85(3):263–276
  4. Whitehead M, Dahlgren G, McIntyre D. Putting equity center stage: challenging evidence-free reforms. International Journal of Health Services. 2007;37(2):353–361
  5. Dans AM, Dans L, Oxman AD, et al. Assessing equity in clinical practice guidelines. Journal of Clinical Epidemiology. 2007;60(6):540–546
  6. Whitehead M. The Concepts and Principles of Equity and Health. EUR/ICP/RPD 414. Copenhagen: World Health Organization Regional Office for Europe; 1990;
  7. Braveman P. Health disparities and health equity: concepts and measurement. Annual Review of Public Health. 2006;27(1):167–194
  8. Gwatkin DR. 10 best resources on … health equity. Health Policy and Planning. 2007;22(5):348–351
  9. Braveman P, Gruskin S. Defining equity in health. Journal of Epidemiology and Community Health. 2003;57(4):254–258
  10. Parkin DM, Bray F. Chapter 2: The burden of HPV-related cancers. Vaccine. 2006;21(24 Suppl 3):S11–S25
  11. Ferlay J, Bray F, Pisani P, et al. Globocan 2002: Cancer Incidence, Mortality and Prevalence Worldwide. [Version 2.0]. 2004. Lyon: IARC Press. IARC CancerBase No. 5.
  12. Kitchener HC, Castle PE, Cox JT. Chapter 7: Achievements and limitations of cervical cytology screening. Vaccine. 2006;21(24 Suppl 3):S63–S70
  13. Sankaranarayanan R, Ferlay J. Worldwide burden of gynaecological cancer: the size of the problem. Best Practice and Research. Clinical Obstetrics & Gynaecology. 2006;20(2):207–225
  14. Palacio-Mejia LS, Rangel-Gomez G, Hernandez-Avila M, et al. Cervical cancer, a disease of poverty: mortality differences between urban and rural areas in Mexico. Salud Pública de México. 2003;45(Suppl 3):S315–S325
  15. O'Brien ED, Bailie RS, Jelfs PL. Cervical cancer mortality in Australia: contrasting risk by aboriginality, age and rurality. International Journal of Epidemiology. 2000;29(5):813–816
  16. Bradley J, Barone M, Mahe C, et al. Delivering cervical cancer prevention services in low-resource settings. International Journal of Gynecology and Obstetrics. 2005;89(Suppl 2):S21–S29
  17. Denny L, Quinn M, Sankaranarayanan R. Chapter 8: Screening for cervical cancer in developing countries. Vaccine. 2006;24(Suppl 3):S71–S77
  18. Gwatkin DR, Bhuiya A, Victora CG. Making health systems more equitable. Lancet. 2004;364(9441):1273–1280
  19. Braveman P, Tarimo E. Social inequalities in health within countries: not only an issue for affluent nations. Social Science and Medicine. 2002;54(11):1621–1635
  20. Bogg L, Hengjin D, Wang K, et al. The cost of coverage: rural health insurance in China. Health Policy and Planning. 1996;11(3):238–252
  21. Msuya JM, Nyaruhucha CN, Kaswahili J. Does preventive health care have a chance in the changing health sector in Tanzania?. East African Medical Journal. 2003;80(3):135–139
  22. Delamonica E, Minujin A, Gulaid J. Monitoring equity in immunization coverage. Bulletin of World Health Organization. 2005;83(5):384–391
  23. UNICEF. Progress for Children: A World Fit for Children. Statistical Review. No.6. New York: UNICEF; 2007;
  24. Horton R. Chronic diseases: the case for urgent global action. Lancet. 2007;370(9603):1881–1882
  25. Elias C, Sherris J. Reproductive and sexual health of older women in developing countries. BMJ (Clinical Research ed.). 2003;327(7406):64–65
  26. Shiffman J. Has donor prioritization of HIV/AIDS displaced aid for other health issues?. Health Policy and Planning. 2008;23(2):95–100
  27. Sinding SW. Keeping sexual and reproductive health at the forefront of global efforts to reduce poverty. Studies in Family Planning. 2005;36(2):140–143
  28. Ahmed A, Vargas Hill R, Smith L, et al. The World's Most Deprived: Characteristics and Causes of Extreme Poverty and Hunger. Report No.2020. Discussion Paper 43. Washington DC: International Food Policy Research Institute; 2007;
  29. Huong DB, Phuong NK, Bales S, et al. Rural health care in Vietnam and China: conflict between market reforms and social need. International Journal of Health Services. 2007;37(3):555–572
  30. Castro-Leal F, Dayton J, Demery L, et al. Public spending on health care in Africa: do the poor benefit?. Bulletin of World Health Organization. 2000;78(1):66–74
  31. McIntyre D, Thiede M, Dahlgren G, et al. What are the economic consequences for households of illness and of paying for health care in low- and middle-income country contexts?. Social Science and Medicine. 2006;62(4):858–865
  32. Houts PS, Lipton A, Harvey HA, et al. Nonmedical costs to patients and their families associated with outpatient chemotherapy. Cancer. 1984;53(11):2388–2392
  33. Stommel M, Given CW, Given BA. The cost of cancer home care to families. Cancer. 1993;71(5):1867–1874
  34. Ohaeri JU, Campbell OB, Ilesanmi AO, et al. The psychosocial burden of caring for some Nigerian women with breast cancer and cervical cancer. Social Science and Medicine. 1999;49(11):1541–1549
  35. Chen M, Vanek J, Lund F, et al. Progress of the World's Women 2005: Women, Work and Poverty. New York: United Nations Development Fund for Women; 2005;
  36. Iyer A, Sen G, George A. The dynamics of gender and class in access to health care: evidence from rural Karnataka, India. International Journal of Health Services. 2007;37(3):537–554
  37. Bingham A, Bishop A, Coffey P, et al. Factors affecting utilization of cervical cancer prevention services in low-resource settings. Salud Pública de México. 2003;45(Suppl 3):S408–S416
  38. Agurto I, Arrossi S, White S, et al. Involving the community in cervical cancer prevention programs. International Journal of Gynecology and Obstetrics. 2005;89(Suppl 2):S38–S45
  39. Knodel J, Watkins S, VanLandingham M. AIDS and older persons: an international perspective. Journal of Acquired Immune Deficiency Syndrome. 2003;33(Suppl 2):S153–S165
  40. UNAIDS. 2004 Report on the Global AIDS Epidemic. 4th Global Report. Geneva: UNAIDS; 2004;
  41. Schatz EJ. “Taking care of my own blood”: older women's relationships to their households in rural South Africa. Scandinavian Journal of Public Health. 2007;69(Suppl):147–154
  42. World Bank. A New Agenda for Women's Health and Nutrition. Washington DC: World Bank; 1994;
  43. Levin CE, Ruel MT, Morris SS, et al. Working women in urban settings: traders, vendors, and food security in Accra. World Development. 1999;27(11):1977–1991
  44. UN Food and Agriculture Organization. Women and food security. FAO Focus March 1997. At: < www.fao.org/FOCUS/E/Women/Sustin-e.htm>. Accessed 3 March 2008
  45. UN Population Fund. Food for the Future: Women, Population, and Food Security. New York: UNFPA; 1996;
  46. Sankaranarayanan R, Gaffikin L, Jacob M, et al. A critical assessment of screening methods for cervical neoplasia. International Journal of Gynecology and Obstetrics. 2005;89(Suppl 2):S4–S12
  47. Sankaranarayanan R, Rajkumar R, Esmy PO, et al. Effectiveness, safety and acceptability of ‘see and treat' with cryotherapy by nurses in a cervical screening study in India. British Journal of Cancer. 2007;96(5):738–743
  48. Sankaranarayanan R, Esmy PO, Rajkumar R, et al. Effect of visual screening on cervical cancer incidence and mortality in Tamil Nadu, India: a cluster-randomised trial. Lancet. 2007;370(9585):398–406
  49. PATH. Innovation in biochemical cervical cancer screening. Seattle: PATH; November 2007;At: < www.path.org/files/RH_start_biochem_scr_fs_en.pdf>. Accessed 10 March 2007
  50. Goldie SJ, Gaffikin L, Goldhaber-Fiebert JD, et al. Cost-effectiveness of cervical cancer screening in five developing countries. New England Journal of Medicine. 2005;353(20):2158–2168
  51. Winkler J, Bingham A, Coffey P, et al. Women's participation in a cervical cancer screening program in northern Peru. Health Education Research. 2008;23(1):10–24
  52. Ault KA. Effect of prophylactic human papillomavirus L1 virus-like-particle vaccine on risk of cervical intraepithelial neoplasia grade 2, grade 3, and adenocarcinoma in situ: a combined analysis of four randomised clinical trials. Lancet. 2007;369(9576):1861–1868
  53. Paavonen J, Jenkins D, Bosch FX, et al. Efficacy of a prophylactic adjuvanted bivalent L1 virus-like-particle vaccine against infection with human papillomavirus types 16 and 18 in young women: an interim analysis of a phase III double-blind, randomised controlled trial. Lancet. 2007;369(9580):2161–2170
  54. Hildesheim A, Herrero R, Wacholder S, et al. Effect of human papillomavirus 16/18 L1 viruslike particle vaccine among young women with preexisting infection: a randomized trial. JAMA. 2007;298(7):743–753
  55. Winer R, Feng Q, Hughes J, et al. Risk of female human papillomavirus acquisition associated with first male sex partner. Journal of Infectious Diseases. 2008;197(2):279–282
  56. Kahn JA, Burk RD. Papillomavirus vaccines in perspective. Lancet. 2007;369(9580):2135–2137
  57. Cutts FT, Franceschi S, Goldie S, et al. Human papillomavirus and HPV vaccines: a review. Bulletin of World Health Organization. 2007;85(9):719–726
  58. UNICEF. State of the World's Children 2008. New York: UNICEF; 2008;
  59. Andre FE, Booy R, Bock HL, et al. Vaccination greatly reduces disease, disability, death and inequity worldwide. Bulletin of World Health Organization. 2008;86(2):140–146
  60. LaMontagne DS, Bingham A, Katahoire A, et al. HPV vaccine implementation in developing countries: understanding the socio-cultural context, health systems environment and policy landscape for successful vaccine delivery. Presented at: 24th International Papillomavirus Conference, Beijing, 7 November 2007.
  61. Instituto de Investigación Nutricional. Strategies for the Introduction of the Human Papillomavirus (HPV) Vaccine for the Prevention of Cervical Cancer: Final Report to PATH. Lima: Instituto de Investigación Nutricional; 2008;(Forthcoming)
  62. Mahoney RT, Maynard JE. The introduction of new vaccines into developing countries. Vaccine. 1999;17(7–8):646–652

PII: S0968-8080(08)32411-2

doi: 10.1016/S0968-8080(08)32411-2

Reproductive Health Matters
Volume 16, Issue 32 , Pages 104-112 , November 2008

Article Tools